![]() | |
Clinical data | |
---|---|
Trade names | Ospolot |
Other names | Sulthiame (AAN AU), sulthiame (USAN US) |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 100% (oral) |
Protein binding | 29% |
Metabolism | Hepatic secretion |
Elimination half-life | 24 hours |
Excretion | Fecal (10%) and renal (90%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.465 |
Chemical and physical data | |
Formula | C10H14N2O4S2 |
Molar mass | 290.35 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Sultiame (or sulthiame) is a sulfonamide and inhibitor of the enzyme carbonic anhydrase. It is used as an anticonvulsant.